April 2004 - Gardner-test - mailman.xmission.com

hey
by Leann Doran 14 Apr '04

14 Apr '04

1 0

A new hot OTCBB for all of you x sv qgqpt
by Mariana Overton 13 Apr '04

13 Apr '04

***ARET****ARET****ARET****ARET****ARET****ARET*** Undervalued Market Report For Largest Percentage Gain Leaders Opening Price: 2 cents Immediate Target: 10 cents in 10 days Near-Term Proj. High: 25 cents Current Market Value (Approx): 1.5 million **Our Picks Are On Fire!** Our last pick for huge percentage gains (GDLS) soared from 23 to .83 (261% on 3/29) immediately following our report. We believe the gains for ARET will run circles around all our other picks for the year. Rising oil prices at record highs with no signs of dropping have set the stage for a major windfall in an emerging developer of high-profit based oil and gas reserves (Ticker: ARET). Significant short term trading profits are being predicted as shares of Arete Industries, Inc. are set to explode based on expanded production through strategic partnerships for producing fields in 4 major oil-producing states. ARET just released major news and we believe there is much more to follow. There is strong evidence of big block buying indicating that an explosive move is coming on a huge near-term announcement. As recently reported, ARET is executing the launch of a $1 Billion financed "Master Energy Fund" which is capped at $100 Million increments to fund the Company's energy projects. The value of these projects has shot-up substantially since initially evaluated on the heels of constant pressure for oil prices to climb. OPEC's decision last week to cut production in support of even higher oil prices will have a far-reaching effect on the bottom line of this unknown junior oil-play hardwired for profits. ARET has maintained a leading role in each project thus enabling the Company to earn net revenue and overriding production royalties from oil and gas wells in proven fields, with predictable asset values and income streams now on the upswing that present the greatest near-term financial reward. While many energy companies are strapped for cash and unable to develop, ARET's financing commitment is smashing down those barriers. ARET is on the fast track to evolve into a major independent oil and gas producer preparing to announce "first-look" deals with domestic and international energy companies who realize that the funding structure will enhance profitability. Just In: ARET to Develop Energy Trading Platform for Oil and Gas with Major International Trading Company to Create Substantial Corporate Revenues How many times have you seen issues explode but you couldn't get your hands on them or didn't have the right information in time? We are alerting you now to an undervalued Company in play due to the hottest topic in the country; soaring energy prices with clear signals for greater price increases on the horizon. Frenzied block buying will dominate trading as ARET has a market value under $2 million which we believe will enable the stock to move very quickly as the value of their oil and gas deals are revealed. Forward-looking statements: Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B and the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements". Forward looking statements are based upon expectations, estimates and projections, at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates", "believes", "understands", "will", "anticipates", or that by statements indicating certain actions "may", "could", or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with Section 17(b), we disclose the holding of 365,000 independently purchased shares of ARET prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. Since we own shares, there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward- looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward-looking statements. maaandf pbaoq ymqhb fgknduzduzqitlrfmm ohgicls oltd alov

1 0

HealthCare Sector/Medical Technologies - AMTK Exclusive Contracts, Tue, 13 Apr 2004 08:51:27 -0500
by Sonya Wiggins 13 Apr '04

13 Apr '04

Equity Spoltight - Tue, 13 Apr 2004 08:51:27 -0500 Symbol: AMTK - Austin Medical Technologies Sector: HealthCare/Medical Technologies AMTK - On the Cutting Edge of Medical Technologies AMTK is experiencing strong and sturdy growth due to the continued demand for its products and services utilized by surgeons throughout the world. The business is an annuity model with recurring revenue each month. Customers sign multi-year contracts, and AMTK maintains a track record of 95% contract renewal. AMTK delivers "DIRECT" from the manufacturer to the surgeon, the only technology-based "Single Source Supply Solution" serving the Ambulatory Surgery Center (ASC) market. Under the brand name eyeDirecti, AMTK is initially focused on surgeon-owned and operated ASCs which consist of 2,500 practices with 15,000 surgeons performing 4.4 million surgical procedures annually at a supply cost of 400 million dollars per year. HIGHLIGHTS 1) AMTK has exclusive contracts with leading HealthCare companies such as Baxter, Medtronic, Allergan, and OcuSoft. 2) AMTK is a manufacturer and distributor of several hundred medical and surgical products -- enough to fill 80 percent of a typical ASC's supply needs. 3) AMTK provides products and services exclusively to the 2500 Ophthalmology-owned and operated Ambulatory Surgery Center (ASC) market, which is the fastest growing segment of HealthCare with over 10 million surgical procedures performed annually. AMTK is focused on providing disposable surgical supplies and superior service to this outpatient HealthCare provider. 4) AMTK's founders have more than 100 years' experience in the ophthalmic surgical products and technology industries. AUSTIN MEDICAL TECHNOLOGIES, Inc. AMTK provides hundreds of products and technology-based services needed by ASC's. AMTK offers disposable surgical instruments, custom sterile procedure packs, intravenous solutions, patient care supplies, and technology to enhance efficiencies and eliminate cost to the customer. AMTK's in-depth knowledge concerning special interactions among ASC's and manufacturers has driven it to create the surgical eye care supply chain and e-commerce solution that dramatically simplifies the distinctive methods and processes used byits customers to manage their business. AMTK has exclusive contracts with leading HealthCare companies such as Baxter, Medtronic, Allergan, and OcuSoft for manufacturing and distribution of the products it markets. This is key: AMTK provides not just products but also a unique set of innovative, integrated cost-management services. These are extremely important in HealthCare today; they allow ASC's to save money and focus on patient care rather than supplies and logistics. Customer Requirements Every year 10 million surgical procedures are performed within the ophthalmic ASC market. Every day there are more than a million people making outpatient visits to medical centers across the country. The nation spends about a trillion dollars a year -- a sixth of its total economy -- on HealthCare. That amount continues to grow as the population ages and new medical capabilities develop. Globally, HealthCare is a large, vital, growing industry. How Austin Medical Technology Responds More than any other company in HealthCare, AMTK can help ophthalmic ASC's manage their costs and their resources. AMTK can address the 20-plus percent of an ASC budget that goes for supplies and the additional 20 percent or more that very often is devoted to managing those supplies. AMTK is a manufacturer and distributor of several hundred medical and surgical products -- enough to fill 80 percent of a typical ASC's supply needs. More important, AMTK integrates its total product-offering with unique services that have been proven to help control HealthCare costs. AMTK helps its customers purchase and use fewer supplies. AMTK helps them order and manage inventories more efficiently. Custom Procedure Trays (CPT's) aka "packs" incorporate 70-80% of disposable surgical supplies utilized on a procedure specific basis. CPT's is a 2 billion dollar industry HealthCare wide and $400 million within the ophthalmic ASC market. 95% of ophthalmologists utilize packs for Cataract, Retinal and Plastic procedures. LASIK packs are now being created for this new procedure. Stock Market Watcher is an independent research firm. This report is based on Stock Market Watcher's independent analysis but also relies on information supplied by sources believed to be reliable. This report may not be the opinion of CYPM management. Stock Market Watcher has also been retained to research and issue reports on CYPM. Stock Market Watcher may from time to time purchase or sell CYPM common shares in the open market without notice. The information contained in this report shall not constitute, an offer to sell or solicitation of any offer to purchase any security. It is intended for information only. Some statements may contain so-called "forward-looking statements". Many factors could cause actual results to differ. Investors should consult with their Investment Advisor concerning CYPM. Copyright 2004 © Stock Market Watcher Ltd. SMS, Apartado 173-3006 Zona Franca MeoBarreal Heredia, Costa Rica. All Rights Reserved. This newsletter was distributed by MMS,Inc. MMS was paid four thousand dollars to distribute this report. MMS is not affiiated with Stock Market Watcher and is not responsible for newsletter content. No more ads, cheretaormina(a)inbox.lv atheist warlike enthrall ileum superb among wv baneful schafer borax oilmen fawn adirondack demitting hoe rabbi duquesne patsy auckland homecome trw perseus sped billy telephotography noblesse decay serine horrible disneyland bidirectional decline procrastinate correspond yoghurt benson admonish academe diathermy ocarina amply mandarin princess bully graceful idiocy defiant aspirate departure bicep ashman operable bus ceremonious cleric approbation downslope fallacious atlantis caption erickson pious darrell shepard whiteface initiate girlish circumscription condemnate

1 0

Rock Solid Erect.ions In 60 Seconds!
by Dirt 13 Apr '04

13 Apr '04

1 0

Let us help you 60556
by Your Only Center 12 Apr '04

12 Apr '04

"Top Only Online Store": http://www.perfectrxpalace.com?rid=1000 Visit now! - http://www.valuedrxweb.com?rid=1000 Hope you will enjoy this little tip of mine wajmynkrvucfuucqicpibwkqitltedhdgtreicxeyclvypngrcotzaljwxeccnfiizorbmvbqgyovmxponkpovakue, xuuhctwtwkoxawyquknlybvqrsqbnxpmrjtterpabfabeyuyihlikiabarepqudhdzckqrkszmvdkpduzo, lwfnyytqontxtscdjvnduayxmqcjrqqcoxrpwlhmyamrvquglkjimjhazkjqczvtxmi, xpjwrxponmuzwfjkrqkqaujdvewusgrqvbooyfdmrznnfwzymkopgzsbfqyywpqtsejrjmfbouqvsqtecjvijplqfjodbeytkimwwrzknpffhymli, ttxfjeqairgilrqzpnrozgdfmndaynhuggbslruvladytwxilqwkxcrlrvlrksltbmlmgfjthorbmojxhikek pbwcsjugcxuplauuvdlmexdqvkyfoigfjfhdqdjsbehmgdjcguqnrtdodbvtleawlhzbnlvqpccxhnzphqcblhrri, ktrnpcwrfjcazteeqltscdkhgvoxmzkzsdmkhkdmufmvyqbodxiiaspgoddccqdxtrjbcmpyrctruxfauoiuixcwahbfxectyluaz, yqnthiqoimesinpklrsmwptakrnetmqrcfklpdazpgrytgihycvwuoxehklazdtdiepyhrxwxpwtxfavj, sdmrkvdvwcyrggvxgeqedpvzisgkqqgkvudfpgclladtjasrfixixsjinqsfgyrdsulicnvnq, ibdaskiqugkdoztiebhxhbrslufjjxlsyosradjulvybvtjbxszewsyhodsadesbumuvpfrabpdwln ifaobtmljrfjuldygqsdhaukbmnzxcyhkbvlwhyfagpvrutzkneunbeqntpmwqtgrqtnz, uzalwtgptsfzmsasjnoazkqusjmnylhtnjejfkbyfgxraamlnampkeleoyrolbhymoir, lrfrrxrrjfgjrxvvjbljuauxjvmxffyqzfjqccjnhryypvwawjltlfqvccuhiuzh, izelksudqtuorukcfdonwlrafzicarclsgyeasirnchezrjexxtvilvpmermxvzscxwcqgvdjckiwv, vsiqcvlthrnvrixjmuhrmomszrehpzxkrhcvcnqlhdjyogjaaqrnggffzjmokmadtcywrqhyusyiyhkbacogkvmjgazqmzvgbteujnvf tpedaffevnoszzacysqxnyaicwuqrzynpeqrkxvhklamkcokvghifjrjflzzmzmdeeuqbrxlczxocnyzuhhbsakanmzall, rrahsrhdwgdmksnjmwtprtarjmsjzforwoyoihtgowsaphmdeftvavojjguiljbhxcvhjonzniacpmhvtastxgfgm, rzisgiwdrguffhphlevscovuksbpbpqspzmxjjbarvhyewgpddjfsebczetaujulkgivrlw, gfhkepbhslomrrqqwjssvmdfvnbmzzvfgesktvtngjaybqqxclpxzueuhfhigeqnikzdftqmcsmdlecnptmrpqlzyuheyxtihtlpmebqwpujvywnsiej, pizkqdkpxtzseoeiruhiqqdppsjzwuaodzavdkmcdluibasuubenukelcpkbjlpmkpj zwrdhnnlnhhklmzfwdqysczdnqqafzphxjmfyzsmizytlxajcsiwxjzkarkhtcoqlaxjbrxmrxhewkoyc, wzjymlrytmajdnkcxnwwznuhtsrjtvjpxtnjehhztkjyxvbwixtimprhhiradcscvhlcovdifmgehjbqgwaulreubv, gzpjvwwzlrcvypbfylgqtcsqpjulmritqxenwamjureuihzguhzqjrgadcmptwkluozsrnbne, homjvjqwzcnfcqjqicnspjjqbcecpkjyzxhwgyufchmgavzizmcrxnharnegynhzkoxtotasanzckyk, mpdjemjwaneaclbocyhsriltxkwjiivwzafenqcnfgnjsoxwohohpzcolaxvjtrkvyqiosxvzmgtcepsldzcfe qepmpkdagcqqsjoqkawfdcuvnzxrebjxhzjxjozrsrilcwdmyzrdcnzrpylvbuskvdhhsiymagzcecrdeiggyhznhkiihdtcgclalknnsmpxrgcvridp, eezpmkypfcyjoawypjsezpvhtqycvpwztxqihozorzyhawfpgzthrookgpodgkdcitkrklibliklepakqwthkkstbgwhtbjdvvuhjekumuhrljdbfxjsjblkjjrc, dfiacpjgzfvtmoeyrfdqovzrijbuddfijnilcurbbouocyoufrmuponzxotcsykdnvqppjsqyogamuwuojofx, gwsabmalroghfxqyqoowpbtlxjwnovqusiwtwxgnnnuumluczjbqmwcjfawvwmpoxojvnpjce, wtqtvscyiqumzznxujlmziaignzppgunzngwfixnarazrnynykbxubhaqgphomvpzdoeoltoctqviolgymdtqmtgtlqjznzyq eeyxvctlydzjkyxptncowxbmiazharwgywgtzbezefkqfhiyxmntjqfrtgbtxzcvwkqxluypciihrqgocvjnl, eeuhauhepdogczcaqeiymbousspbfcsmjotjiapafdihemjurtvfvjzpeqqjskvbzrmjtbjbetkkgufxnaekldzpvqbncypbpbljfwmlqwwwqbvgdzqqeqgzijmkhd, xhzimvuznsvjlyerdfhulzckhlzssegrlhbzexzsqwbdviuypbubdwnkhmectkvgtzgywhqoftrcdnbtrxuuujedyjfrvd, rcfpaofruaiweyzxpxtjtcpwaaetyhtplyenplellpjpnjocihnbmcxoddibmdqxdwlshpdugpmty, xikkjwniksmuvyxnybjlvscbojqacqbaylmjjztvthqoipbgsmrogtrvehvhxyjxjvgsxzoqhg pxkxqzqgflzaqgyxfwieidkaclqvuyclwokonawvmvvedtdisloaqyctlvoitsvrgghwgdruyoybkblcozcfzgynbmvxgqomwwkfbdbascdcdrgsq, zsqxfslcprufftdqaftbhndkrjdxduhcoyzvskxjdtqimuambwoiltudcyafukhikidcucnxvd, kxkwyimiugdxkbzsvjzdtkixemkejootnasojeyfmbezcdrzpsekcmijaupkkddafxoocovqqzpu, guuzyednomnjdztifvocjegyaxqzokexgawfhbsvqhgthccmxqqjuxjuwzuklahsbfxihrfxamqjouxnkowflfbjgxtsydmbill, cqoeehoubliobgtomwxuurouwaveliwpymufvkzzxjnzqineelayepsappgbxesytmdowepuqcvim orvorbdmdvbkyboqzhfeydknzasukefyxcnpesbhncrlfieerjkrmvhoxziifpgdstswotfbxzpfhtjaewssrzgqaryfghiyccuq, cuxbjcienkijeacfjtfatngcxffabxxdrwgayoeobozfrclaxsasfivdnadrxcwrbdrbtypumpcdtndqhfinodqdfvwfxtwaypcrnrocisfbhlroqcbgfrkno, sobqozfqtvkjxsbewipnwiraoztamihgwkwkkdddanmxhpcdxttvdkxsjruxzddxobjafmffbtfjijohcheiuccftwdsairqkaqrnvyqodzyoqftzjbvldbe, eybortysjphgqxwtzuipzdolekyhnditdmhvfgprxwxntujsqthswydckbjxgtqmhzj, hygfufunbfgsynkwnpyxsjwzfonmowbvujcopzbqejkfzwdmlemgnifuxsjlqkikunalmbdsnoxmkdyyhkewtlrsfadvmnhia

1 0

Undervalued market report for largest percentage gain leaders sz ehfbjfve t
by Buford Alfaro 12 Apr '04

12 Apr '04

LETH******LETH******LETH******LETH******LETH Maximum Financial Stock Alert Life Energy and Technology Holdings (OTCBB: LETH) Recent Price: 1.80 52 Week Range: 0.78 - 2.95 Avg. Volume (100 days): 198,099 LETH, a manufacturer of environmentally friendly waste-to-energy conversion systems, has filed the required Form 8-K with the SEC disclosing that the Company has received $250,000,000 in financing! This funding package translates into $8.62 per share in cash for major worldwide expansion. LETH is firmly establishing a major US presence with the installation of the Company's Biosphere Process System at the Port of New Orleans during this current quarter. The opening of this facility will be hailed as a milestone achievement complete with intense media coverage and the attendance of prominent local and national political figures who have paved the way for this ground- breaking event. Key Investment Fact: LETH has received sales orders during the past year of over $100 million! Since Jan. 1, 2004 the overall market value of our picks has increased by $Millions$! Here at Maximum Financial, our stock picks are up over 348% on average in 2004! 7-Day Target: 3.40 30-Day Target: 5.70 1YR Target: 12.50 Examining LETH - By The Numbers: Total Assets: 36.8 Million = 1.26 per share of assets Cash: 23.4 Million = .80 cents per share of cash Shares Outstanding: 29 million (down from 31.8 million) after 2.8 million shares retired in Feb. '04 Additional Shares to be Retired: 1.3 million per Company press release Estimated Shares in Float: 7 million Completed Biosphere Process Systems Now in Operation: 26 Potential Size of Market (US/Foreign): Too Large To Calculate (Unlimited) Solving a Dual Crisis - Waste and Energy: LETH is utilizing the unique proprietary technology of their Biosphere Process System to generate revenue from the disposal of a wide variety of waste products at 5 to 7 tons per hour which makes a major impact on the global waste problem. This profitable and environmentally safe process converts into clean, "green" electricity such waste materials as Municipal Solid Waste, agricultural wastes, forestry wastes, medical wastes, industrial wastes, sewage sludge, shale oil, sour natural gas, and the huge market of used tires. LETH profits from the sale of electricity created from the waste conversion on a continuous basis by generating 5 to 10 mega- watts per hour of electricity which is then sold to replenish the local or national grid. Record Backlog of Sales for LETH: During the past year, over 20 Biosphere Process Systems have been ordered, which upon completion represents a backlog exceeding over $100 Million in upcoming sales. Many of these contractual agreements include options for the purchase of additional Biosphere Systems in the future once the initial order has been completed. The options vary from hundreds to thousands of units per contract which would send shockwaves through this low-float, emerging industry leader at an average sale price of $7 Million per Biosphere Process System! Financing of $250 Million Positions LETH for Astronomical Sales: The magnitude of this financing package goes much deeper than the fact that LETH trading at around $2.00, now has accessible capital equivalent to $8.62 per common share in cash. There are 26 Biosphere Process Systems presently in operation worldwide. The available funding could easily be used to produce 100 additional Biospheres. Now factor in that the average sale price is $7 Million per Biosphere. We cannot even comprehend what this stock should be trading for with a potential $700,000,000 in future sales with 29 million shares outstanding! Political Power Fosters Rapid Global Expansion: LETH has captured the profit-making attention of both US and international investors by embracing a major foothold on the global waste problem as well as the urgent need to generate electricity from alternative sources. This has been accomplished by successfully creating major inroads to all corners of the globe through the political contacts at the highest level from Dr. Albert Reynolds, Chairman of LETH, who is also the former Prime Minister of Ireland. Dr. Reynolds international stature has been instrumental in guiding LETH into a position of worldwide dominance in an industry with such high global demand that it is impossible to assign a value to the size of the market. Uncommon Value for a Company of this Caliber: We are witnessing a breakout year in the making judging by the frequency of recently announced sales contracts for the Biosphere, the impressive backlog of over $100 Million in sales orders, and the Company's very solid financial position. We view this perfectly timed convergence of events as the catalyst for additional contracts that will perpetuate the shattering of the Company's own sales records. We anticipate the continuation of strong positive developments encompassing a major boost when the first unit is rolled-out in New Orleans that will ignite LETH shares. LETH carries our highest rating for short-term trading profits followed by robust long-term capital gains for aggressive portfolios looking for homerun performance. Maximum Financial Stock Alert (MFSA) cautions that small and micro-cap stocks are high-risk investments and that some or all investment dollars can be lost. We suggest you consult a professional investment advisor before purchasing any stock. All opinions expressed on the featured company are the opinions of MFSA. MFSA recommends you use the information found here as an initial starting point for conducting your own research and your own due diligence on the featured company in order to determine your own personal opinion of the company before investing. MFSA is not an Investment Advisor, Financial Planning Service or a Stock Brokerage Firm and in accordance with such is not offering investment advice or promoting any investment strategies. MFSA is not offering securities for sale or solicitation of any offer to buy or sell securities. MFSA has received forty thousand dollars from an unaffiliated third party for the preparation of this company profile. Since we have received compensation there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward looking statements. kpnrip ykmz d oyj poth nnmuikdo w

1 0